Abstract
Purpose
Bronchiectasis is a chronic disease, leading to worsening of health-related quality of life. This study evaluated the psychometric properties of a new patient-reported outcome for non-cystic fibrosis bronchiectasis, the Quality of Life Questionnaire Bronchiectasis, translated into Spanish (QOL-B-Sp-V3.0).
Methods
This prospective study recruited clinically stable patients with non-cystic fibrosis bronchiectasis at 4 Spanish centers. Health status was assessed with multiple indicators (dyspnea, exacerbations, bronchorrhea, etc.), microbiological, radiological, spirometric, and anthropometric parameters plus St-George Respiratory Questionnaire (SGRQ). Psychometric analyses included internal consistency, test–retest reliability, convergent validity, predictive validity, and responsivity to change.
Results
The 207 stable patients (mean age 57.2 years) had a Bhalla score of 11.53 ± 7.39 and FEV1% of 68.3 ± 22.2 %. One hundred and sixty-one stable patients repeated the test 2 weeks later, and 80 patients who had an exacerbation within 6 months of the assessment also repeated it. Internal consistency was high across all scales (Cronbach’s alpha >0.70). Thirty-six of 37 items correlated more strongly with their assigned scale than a competing scale. Test–retest coefficients were strong (intraclass correlations r = 0.68–0.88). All scales, except Treatment Burden, discriminated significantly between patients with mild, moderate, and severe disease according to FEV1% and other respiratory parameters. Strong convergence was found between the QOL-B-Sp-V3.0 and SGRQ. Significant correlations were found between QOL-B-Sp-V3.0 and various clinical, spirometric, radiological, and anthropometric variables. Significant differences were found on all QOL-B-Sp-V3.0 scales, except emotional functioning, between the baseline responses and onset of an exacerbation; robust sensitivity to change was observed on the Respiratory Symptoms scale.
Conclusions
The QOL-B-Sp-V3.0 questionnaire demonstrated strong reliability and validity. Scores were reproducible after 2 weeks, and it discriminated between patients who varied in severity and was responsive to changes related to exacerbation.
Similar content being viewed by others
Abbreviations
- BQ:
-
Bronchiectasis
- BMI:
-
Body mass index
- CDRQ:
-
Chronic Respiratory Disease Questionnaire
- CF:
-
Cystic fibrosis
- CFQ-R:
-
Cystic Fibrosis Questionnaire Revised
- FEV1 :
-
Forced spirometry volume in the first second
- HI:
-
Haemophilus influenzae
- HRCT:
-
High-resolution computed tomography
- HRQOL:
-
Health-related quality of life
- LCQ:
-
Leicester Cough Questionnaire
- MID:
-
Minimal important difference score
- MRC:
-
Medical Research Council
- PA:
-
Pseudomonas aeruginosa
- PRO:
-
Patient-reported outcome
- QOL-B-Sp:
-
Quality of Life Questionnaire for patients with Bronchiectasis. Spanish version
- SEPAR:
-
Spanish Society of Pulmonology and Thoracic Surgery
- SGRQ:
-
St. George Respiratory Questionnaire
References
Vendrell, M., de Gracia, J., Olveira, C., et al. (2008). Diagnosis and treatment of bronchiectasis. Recommendations of The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Archivos de Bronconeumologia, 44, 629–640.
Pasteur, M. C., Bilton, D., Hill, A. T., & On behalf of the British Thoracic Society Bronchiectasis (non-CF) Guidelines Group. (2010). British Thoracic Society for non-CF bronchiectasis. Thorax, 65, i1–i58.
O’Leary, C. J., Wilson, C. B., Hansell, D. M., Cole, P. J., Wilson, R., & Jones, P. W. (2002). Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respiratory Medicine, 96, 686–692.
Olveira, C., Olveira, G., Gaspar, I., et al. (2013). Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Quality of Life Research, 22, 597–605.
Olveira, G., Olveira, C., Gaspar, I., et al. (2010). Validation of the Spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14 + Spain). Archivos de Bronconeumologia, 46, 165–175.
Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of The Cystic Fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest Journal, 128, 2347–2354.
US Food and Drug Administration. (2009). Guidance for industry patient-reported outcome measures: Use in medial product development to support label ing claims. Retrieved April 13, 2011. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. American Journal of Respiratory and Critical Care Medicine, 145, 1321–1327.
Padilla, A., Olveira, G., Olveira, C., et al. (2007). Validity and reliability of the St George’s Respiratory Questionnaire in adults with cystic fibrosis. Archivos de Bronconeumologia, 43, 205–211.
Martínez-García, M. A., Perpiñá Tordera, M., Román Sánchez, P., & Soler Cataluña, J. J. (2005). Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis. Archivos de Bronconeumologia, 41, 110–117.
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., et al. (2009). Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest Journal, 135, 1223–1232.
Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005). Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest Journal, 128, 739–745.
Wilson, C. B., Jones, P. W., O’Leary, C. J., Hansell, D. M., Cole, P. J., & Wilson, R. (1997). Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. European Respiratory Journal, 10, 1754–1760.
Chan, S. L., Chan-Yeung, M. M., Ooi, G. C., et al. (2002). Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest Journal, 122, 2030–2037.
Jones, P. W. (2002). Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal, 19, 398–404.
Martínez-García, M. A., Soler-Cataluña, J. J., Catalán-Serra, P., Román-Sánchez, P., & Tordera, M. P. (2012). Clinical efficacy and safety of budesonide formoterol in non-cystic fibrosis BQ. Chest Journal, 141, 461–468.
Murray, M. P., Turnbull, K., Mac Quarrie, S., Pentland, J. L., & Hill, A. T. (2009). Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. European Respiratory Journal, 34, 125–131.
Reda, A. A., Kotz, D., Kocks, J. W., Wesseling, G., & Van Schayck, C. P. (2010). Reliability and validity of the clinical COPD questionnaire and chronic respiratory questionnaire. Respiratory Medicine, 104, 1675–1682.
Quittner, A. L., Cruz, I., Marciel, K. K., Ilowite, J., Gotfried, M. H., & Barker, A. (2009). A new PRO for non-CF bronchiectasis: Associations between the QOL-B and health outcomes. [Abstract]. European Respiratory Journal, 34(Suppl. 53), 1010.
Quittner, A. L., Salathe, M., Gotfried, M., et al. (2010). National validation of a patient-reported outcome measure for bronchiectasis: Psychometric results on the QOL-B.[Abst.] American Journal of Respiratory Critical Care Medicine A5793. www.atsjournals.org Online Abstracts Issue.
Quittner, A. L. (2012). Development of a disease-specific PRO for non-CF bronchiectasis: The QOL-B FDA Workshop 2012.
Naidich, D. P., McCauley, D. I., Khouri, N. F., Stitik, F. P., & Siegelman, S. S. (1982). Computed tomography of bronchiectasis. Journal of Computer Assisted Tomography, 6, 437–444.
Rosenstein, B. J., & Cutting, G. R. (1998). The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics, 132, 589–595.
Medical Research Council. (1982). Committee on research into chronic bronchitis: Instruction for use on the questionnaire on respiratory symptoms. In S. M. Brooks (Ed.), Surveillance for respiratory hazards (Vol. 8, pp. 12–16). ATS News. Devon: WJ Holman 1966.
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40, 373–383.
Roca, J., Sanchis, J., Agustí Vidal, A., et al. (1986). Spirometric reference values for a Mediterranean population. Bulletin Européen de Physiopathologie Respiratoire, 22, 217–224.
Bhalla, M., Turcios, N., Aponte, V., et al. (1991). Cystic fibrosis: Scoring system with thin-section CT. Radiology, 179, 783–788.
Snider, G. L., Kory, R. C., & Lyons, H. A. (1967). Grading of pulmonary function impairment by means of pulmonary function test. Diseases of the Chest, 52, 270–271.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum Associates.
Quittner, A. L., Avani Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest Journal, 135, 1610–1618.
Quittner, A. L., Sawicki, G. S., Mc Mulen, A., et al. (2012). Psychometric evaluation of the Cystic Fibrosis Questionnaire-revised in a national US simple. Quality of Life Research, 21, 1279–1290.
Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97.
Bregnballe, V., Thastum, M., Lund, L., Hansen, C. R., Preissler, T., & Schiøtz, P. O. (2008). Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). Journal of Cystic Fibrosis, 7, 531–536.
Wilson, C. B., Jones, P. W., O’Leary, C. J., Cole, P. J., & Wilson, R. (1997). Validation of the St George’s Respiratory Questionnaire in bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 156, 536–541.
Olveira, G., Olveira, C., Gaspar, I., et al. (2011). Malnutrition and inflammation in patients with bronchiectasis. Clinical Nutrition, 6(suppl 1), 150–151.
Olveira, G., Olveira, C., Gaspar, I., et al. (2012). Fat-free mass depletion and inflammation in patients with bronchiectasis. Journal of the Academy of Nutrition and Dietetics, 112, 1999–2006.
Olveira, G., Olveira, C., Dorado, A., et al. (2013). Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clinical Nutrition, 32, 112–117.
Acknowledgments
This study was supported by a grant from SEPAR (31/2011).
Author information
Authors and Affiliations
Corresponding author
Additional information
This study is included in the PII of Bronchiectasis of SEPAR (Spanish Society of Pulmonology and Thoracic Surgery).
Montserrat Vendrell (Universitary Hospital Dr Josep Trueta, Gerona, Spain) and Nuria Porras (Endocrinology and Nutrition Service, Carlos Haya University Hospital, Malaga, Spain) also participated in this study.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Olveira, C., Olveira, G., Espildora, F. et al. Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0. Qual Life Res 23, 1279–1292 (2014). https://doi.org/10.1007/s11136-013-0560-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0560-0